Clinical Trial Update: Tocilizumab Effect iN pOlymyalgia Rheumatica [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tocilizumab for polymyalgia rheumatica has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polymyalgia Rheumatica

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: University Hospital, Brest | Conditions: Polymyalgia Rheumatica | Phase 2 | Status: COMPLETED